Related Experiment Video
Updated: Apr 29, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice
Steven J Frank1, James D Cox1, Michael Gillin2
1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
This study presents the initial clinical outcomes of multifield optimization intensity modulated proton therapy (MFO-IMPT) for head and neck cancers. The treatment demonstrated a high response rate with manageable side effects, suggesting promise for future trials.
Area of Science:
- Radiation Oncology
- Medical Physics
- Oncology
Background:
- Head and neck tumors present complex treatment challenges due to proximity to critical structures.
- Intensity Modulated Proton Therapy (IMPT) offers potential for precise dose delivery, minimizing toxicity.
- Multifield Optimization (MFO) is an advanced technique within IMPT aiming to further improve dose distribution.
Purpose of the Study:
- To report the first clinical experience and toxicity profile of MFO-IMPT in patients with head and neck tumors.
- To evaluate the feasibility and early clinical outcomes of this novel treatment approach.
Main Methods:
- Fifteen patients with head and neck cancer (including SCC and adenoid cystic carcinoma) received MFO-IMPT.
- Treatment involved active scanning beam proton therapy with doses of 70 Gy (chemoradiation) or 66 Gy (radiation alone).
- Plan robustness was assessed against setup uncertainties and proton range variations.
Main Results:
- All 15 patients completed MFO-IMPT without treatment breaks or hospitalizations; no treatment-related deaths occurred.
- A high overall clinical complete response rate of 93.3% was observed at a median follow-up of 28 months.
- Common toxicities included xerostomia (all patients) and mucositis (all patients), with no grade 2+ anterior oral mucositis.
Conclusions:
- This is the first clinical report detailing the use of MFO-IMPT for head and neck tumors.
- Early clinical outcomes, including a high response rate and manageable toxicity, are encouraging.
- Further investigation in prospective clinical trials is warranted to confirm the efficacy of MFO-IMPT.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
10:25Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
Published on: April 12, 2024